eli lilly glp 1 weight loss orforglipron oral GLP-1 phase 3 trial Eli Lilly's Experimental GLP-1 Pill

Contact your GP or healthcare provider if you experience: Severe or worsening joint pain that interferes with daily activities or does not improve with simple measures Joint swelling, redness, or warmth , which may indicate inflammation or infection Sudden onset of intense pain in a single joint, particularly if accompanied by fever (may require same-day assessment to exclude septic arthritis or gout) Joint pain associated with systemic symptoms such as unexplained fever, weight loss (beyond expected treatment effects), rash, or general malaise Persistent pain lasting more than two weeks despite self-care measures Joint stiffness lasting more than 30 minutes after waking , which may suggest inflammatory arthritis Reduced range of motion or inability to bear weight on affected joints Seek urgent medical attention (contact 111 or attend A&E) if: Joint pain is accompanied by severe abdominal pain, persistent vomiting, or signs of pancreatitis (if pancreatitis is suspected, stop your GLP-1 medication immediately

A Strategic Decision Not a Simple Yes or No Employers must balance clinical effectiveness, cost sustainability, and operational feasibility

Pagano G, Polychronis S, Wilson H, Giordano B, Ferrara N, Niccolini F, et al

We understood the therapy and knew people deserved better than a generic calorie counter

Instead, they mimic the effects of GLP-1 hormone by activating the same receptors as your home-made hormone

On safety, the GI profile broadly mirrors the peptides